Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Transfusion Reaction | 5 | 2018 | 245 | 2.96 | Why? |
| Blood Transfusion | 4 | 2019 | 1399 | 1.46 | Why? |
| Transfusion-Related Acute Lung Injury | 2 | 2019 | 63 | 1.42 | Why? |
| Pulmonary Edema | 2 | 2019 | 430 | 1.10 | Why? |
| Erythrocyte Transfusion | 4 | 2018 | 386 | 1.08 | Why? |
| Blood Safety | 2 | 2017 | 459 | 0.93 | Why? |
| Catheterization, Central Venous | 4 | 2021 | 458 | 0.79 | Why? |
| Endotoxemia | 2 | 2018 | 143 | 0.74 | Why? |
| Disease | 1 | 2020 | 126 | 0.74 | Why? |
| Blood Preservation | 4 | 2019 | 191 | 0.72 | Why? |
| Lipopolysaccharides | 4 | 2018 | 848 | 0.70 | Why? |
| Catheters, Indwelling | 1 | 2018 | 84 | 0.69 | Why? |
| Biotinylation | 4 | 2019 | 55 | 0.62 | Why? |
| Acute Lung Injury | 2 | 2017 | 904 | 0.60 | Why? |
| Erythrocytes | 5 | 2018 | 617 | 0.56 | Why? |
| Catheterization, Peripheral | 1 | 2018 | 249 | 0.56 | Why? |
| Platelet Transfusion | 3 | 2019 | 209 | 0.49 | Why? |
| Natriuretic Peptide, Brain | 1 | 2018 | 1215 | 0.44 | Why? |
| Erythrocyte Aging | 1 | 2010 | 13 | 0.44 | Why? |
| Renal Insufficiency | 1 | 2017 | 810 | 0.41 | Why? |
| Cell Tracking | 2 | 2019 | 10 | 0.39 | Why? |
| Risk Management | 1 | 2017 | 1044 | 0.38 | Why? |
| Peptide Fragments | 1 | 2018 | 2075 | 0.35 | Why? |
| Noninvasive Ventilation | 1 | 2021 | 2329 | 0.34 | Why? |
| Hemorrhage | 2 | 2018 | 3013 | 0.30 | Why? |
| Dyspnea | 1 | 2018 | 3847 | 0.29 | Why? |
| Extracorporeal Membrane Oxygenation | 2 | 2021 | 5002 | 0.28 | Why? |
| Consensus | 1 | 2019 | 6345 | 0.27 | Why? |
| Biotin | 3 | 2019 | 52 | 0.26 | Why? |
| Blood Coagulation Disorders | 1 | 2017 | 2040 | 0.26 | Why? |
| Healthy Volunteers | 3 | 2018 | 1444 | 0.25 | Why? |
| Muscle Fibers, Skeletal | 1 | 2021 | 31 | 0.22 | Why? |
| Surveys and Questionnaires | 3 | 2018 | 43792 | 0.20 | Why? |
| Intensive Care Units | 7 | 2021 | 29594 | 0.20 | Why? |
| Perfusion | 1 | 2020 | 254 | 0.19 | Why? |
| Respiratory Insufficiency | 1 | 2021 | 7301 | 0.19 | Why? |
| Central Venous Catheters | 1 | 2021 | 188 | 0.19 | Why? |
| Chromates | 1 | 2017 | 1 | 0.18 | Why? |
| Gonadal Steroid Hormones | 1 | 2021 | 328 | 0.18 | Why? |
| Staining and Labeling | 1 | 2019 | 169 | 0.18 | Why? |
| Critical Illness | 7 | 2021 | 17281 | 0.18 | Why? |
| Spectrophotometry | 1 | 2017 | 34 | 0.18 | Why? |
| Physicians | 1 | 2017 | 4214 | 0.18 | Why? |
| Diaphragm | 1 | 2021 | 232 | 0.17 | Why? |
| Classification | 1 | 2017 | 55 | 0.17 | Why? |
| Glucosephosphate Dehydrogenase | 1 | 2017 | 85 | 0.17 | Why? |
| Macrophages, Alveolar | 1 | 2021 | 668 | 0.16 | Why? |
| Heterozygote | 1 | 2017 | 249 | 0.16 | Why? |
| Cell Adhesion | 1 | 2017 | 230 | 0.16 | Why? |
| Heart Failure | 1 | 2017 | 6638 | 0.15 | Why? |
| Risk Factors | 9 | 2020 | 71621 | 0.15 | Why? |
| Cannula | 1 | 2021 | 750 | 0.15 | Why? |
| Volatile Organic Compounds | 1 | 2017 | 187 | 0.14 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.14 | Why? |
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2017 | 198 | 0.14 | Why? |
| Male | 25 | 2021 | 367725 | 0.14 | Why? |
| Sodium Chloride | 2 | 2018 | 203 | 0.13 | Why? |
| Humans | 41 | 2021 | 930598 | 0.13 | Why? |
| Breath Tests | 1 | 2017 | 338 | 0.13 | Why? |
| Positive-Pressure Respiration | 2 | 2021 | 1160 | 0.13 | Why? |
| Netherlands | 5 | 2021 | 3533 | 0.13 | Why? |
| Exhalation | 1 | 2017 | 441 | 0.13 | Why? |
| Incidence | 4 | 2020 | 25622 | 0.12 | Why? |
| Patients | 1 | 2020 | 1167 | 0.12 | Why? |
| Flow Cytometry | 2 | 2019 | 2393 | 0.12 | Why? |
| Female | 23 | 2021 | 380317 | 0.12 | Why? |
| Venous Thromboembolism | 2 | 2020 | 4273 | 0.11 | Why? |
| Calcium | 1 | 2017 | 708 | 0.11 | Why? |
| Extracellular Vesicles | 1 | 2018 | 607 | 0.11 | Why? |
| von Willebrand Factor | 1 | 2017 | 668 | 0.11 | Why? |
| Blood Platelets | 2 | 2019 | 1704 | 0.11 | Why? |
| Antibodies | 1 | 2017 | 846 | 0.10 | Why? |
| Pneumonia | 1 | 2010 | 5652 | 0.10 | Why? |
| Kinetics | 1 | 2018 | 3238 | 0.10 | Why? |
| Hospitals, Teaching | 1 | 2018 | 1609 | 0.10 | Why? |
| Middle Aged | 17 | 2021 | 270681 | 0.10 | Why? |
| Denmark | 1 | 2017 | 2654 | 0.10 | Why? |
| Coronary Angiography | 1 | 2019 | 2275 | 0.09 | Why? |
| Out-of-Hospital Cardiac Arrest | 1 | 2019 | 1047 | 0.09 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2018 | 10649 | 0.09 | Why? |
| Biomarkers | 5 | 2021 | 23361 | 0.09 | Why? |
| Nucleocapsid Proteins | 1 | 2020 | 3120 | 0.09 | Why? |
| Internationality | 1 | 2021 | 3297 | 0.09 | Why? |
| Fibrin Fibrinogen Degradation Products | 2 | 2020 | 5993 | 0.08 | Why? |
| Oxygen Inhalation Therapy | 1 | 2021 | 3629 | 0.08 | Why? |
| Rats, Sprague-Dawley | 1 | 2010 | 987 | 0.08 | Why? |
| Antibody Formation | 1 | 2020 | 4038 | 0.08 | Why? |
| Respiration, Artificial | 3 | 2021 | 22116 | 0.08 | Why? |
| Adult | 12 | 2021 | 244371 | 0.08 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.08 | Why? |
| Thrombosis | 2 | 2021 | 7504 | 0.08 | Why? |
| Glycosylation | 2 | 2021 | 1255 | 0.08 | Why? |
| Aged | 13 | 2021 | 215776 | 0.08 | Why? |
| Chromatography, High Pressure Liquid | 1 | 2010 | 669 | 0.08 | Why? |
| Case-Control Studies | 3 | 2021 | 17671 | 0.07 | Why? |
| Computer Simulation | 1 | 2020 | 4982 | 0.07 | Why? |
| Venous Thrombosis | 1 | 2020 | 2739 | 0.07 | Why? |
| Electrocardiography | 1 | 2019 | 3957 | 0.07 | Why? |
| Hematologic Neoplasms | 1 | 2018 | 2105 | 0.07 | Why? |
| Mass Spectrometry | 1 | 2010 | 1165 | 0.07 | Why? |
| Thrombocytopenia | 1 | 2018 | 2093 | 0.07 | Why? |
| Aerosols | 1 | 2021 | 5393 | 0.07 | Why? |
| Patient Admission | 1 | 2021 | 5250 | 0.07 | Why? |
| Retrospective Studies | 6 | 2021 | 105322 | 0.07 | Why? |
| Antibodies, Viral | 3 | 2021 | 51949 | 0.07 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.07 | Why? |
| Data Interpretation, Statistical | 2 | 2018 | 657 | 0.06 | Why? |
| Cell Survival | 2 | 2019 | 1581 | 0.06 | Why? |
| Models, Statistical | 1 | 2020 | 5312 | 0.06 | Why? |
| Rats | 1 | 2010 | 2764 | 0.06 | Why? |
| Sex Hormone-Binding Globulin | 1 | 2021 | 57 | 0.06 | Why? |
| Percutaneous Coronary Intervention | 1 | 2019 | 3646 | 0.06 | Why? |
| Time-to-Treatment | 1 | 2019 | 5883 | 0.06 | Why? |
| Chemotaxis | 1 | 2021 | 67 | 0.06 | Why? |
| Heart Diseases | 1 | 2019 | 3503 | 0.06 | Why? |
| Fucose | 1 | 2020 | 38 | 0.06 | Why? |
| Parvovirus B19, Human | 1 | 2020 | 73 | 0.05 | Why? |
| Pulmonary Embolism | 1 | 2020 | 4775 | 0.05 | Why? |
| Multicenter Studies as Topic | 2 | 2018 | 2437 | 0.05 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.05 | Why? |
| Fibroblast Growth Factors | 1 | 2021 | 119 | 0.05 | Why? |
| Neutrophils | 1 | 2017 | 5476 | 0.05 | Why? |
| Thrombophlebitis | 1 | 2020 | 94 | 0.05 | Why? |
| Tomography, X-Ray Computed | 3 | 2021 | 25144 | 0.05 | Why? |
| Estradiol | 1 | 2021 | 250 | 0.05 | Why? |
| Albumins | 1 | 2021 | 324 | 0.05 | Why? |
| Virus Diseases | 1 | 2017 | 3779 | 0.05 | Why? |
| Annexin A5 | 1 | 2018 | 22 | 0.05 | Why? |
| Drug Stability | 1 | 2019 | 236 | 0.05 | Why? |
| Mannitol | 1 | 2018 | 34 | 0.05 | Why? |
| Cell Shape | 1 | 2018 | 57 | 0.05 | Why? |
| Hepatitis B Vaccines | 1 | 2020 | 245 | 0.05 | Why? |
| Succinimides | 1 | 2017 | 3 | 0.04 | Why? |
| Phosphatidylserines | 1 | 2018 | 99 | 0.04 | Why? |
| Immunologic Tests | 1 | 2020 | 445 | 0.04 | Why? |
| Lung | 3 | 2021 | 31049 | 0.04 | Why? |
| Cells, Cultured | 2 | 2020 | 5835 | 0.04 | Why? |
| Discriminant Analysis | 1 | 2017 | 170 | 0.04 | Why? |
| Fibrosis | 1 | 2021 | 800 | 0.04 | Why? |
| Aged, 80 and over | 2 | 2017 | 88759 | 0.04 | Why? |
| Gas Chromatography-Mass Spectrometry | 1 | 2017 | 187 | 0.04 | Why? |
| Indicators and Reagents | 1 | 2018 | 183 | 0.04 | Why? |
| Agglutination Tests | 1 | 2017 | 124 | 0.04 | Why? |
| Transplantation, Autologous | 1 | 2018 | 364 | 0.04 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2017 | 6653 | 0.04 | Why? |
| Least-Squares Analysis | 1 | 2017 | 254 | 0.04 | Why? |
| Immunoglobulin Fc Fragments | 1 | 2020 | 691 | 0.04 | Why? |
| Graft Survival | 1 | 2019 | 587 | 0.04 | Why? |
| Respiratory Tract Infections | 1 | 2017 | 6817 | 0.04 | Why? |
| Sodium | 1 | 2018 | 309 | 0.04 | Why? |
| Sample Size | 1 | 2018 | 518 | 0.04 | Why? |
| Testosterone | 1 | 2021 | 596 | 0.04 | Why? |
| Adenosine Triphosphate | 1 | 2018 | 294 | 0.04 | Why? |
| Interleukins | 1 | 2021 | 762 | 0.04 | Why? |
| Patients' Rooms | 1 | 2020 | 675 | 0.04 | Why? |
| Cytomegalovirus | 1 | 2020 | 600 | 0.04 | Why? |
| Potassium | 1 | 2018 | 325 | 0.04 | Why? |
| Human Umbilical Vein Endothelial Cells | 1 | 2017 | 286 | 0.04 | Why? |
| Adenine | 1 | 2018 | 463 | 0.04 | Why? |
| Vaccines, Subunit | 1 | 2020 | 1088 | 0.03 | Why? |
| Hydrogen-Ion Concentration | 1 | 2018 | 993 | 0.03 | Why? |
| Biological Assay | 1 | 2017 | 367 | 0.03 | Why? |
| Single-Blind Method | 1 | 2018 | 1283 | 0.03 | Why? |
| HIV | 1 | 2020 | 1116 | 0.03 | Why? |
| Glucose | 1 | 2018 | 573 | 0.03 | Why? |
| ADAMTS13 Protein | 1 | 2017 | 363 | 0.03 | Why? |
| Platelet Count | 1 | 2019 | 1381 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2017 | 15421 | 0.03 | Why? |
| Infusions, Intravenous | 1 | 2017 | 1224 | 0.03 | Why? |
| Disease-Free Survival | 1 | 2018 | 1654 | 0.03 | Why? |
| Metabolome | 1 | 2017 | 624 | 0.03 | Why? |
| Young Adult | 3 | 2020 | 93724 | 0.03 | Why? |
| Hospital Bed Capacity | 1 | 2020 | 1300 | 0.03 | Why? |
| Evidence-Based Practice | 1 | 2018 | 693 | 0.03 | Why? |
| Disease Models, Animal | 1 | 2010 | 10998 | 0.03 | Why? |
| Hemoglobins | 1 | 2018 | 958 | 0.03 | Why? |
| Health Services Research | 1 | 2018 | 756 | 0.03 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.03 | Why? |
| Interleukin-6 | 2 | 2020 | 7522 | 0.03 | Why? |
| Infant | 3 | 2017 | 30274 | 0.02 | Why? |
| Respiratory Function Tests | 1 | 2017 | 1755 | 0.02 | Why? |
| Prospective Studies | 3 | 2021 | 43301 | 0.02 | Why? |
| Adolescent | 2 | 2017 | 86841 | 0.02 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2019 | 4260 | 0.02 | Why? |
| Convalescence | 1 | 2020 | 2829 | 0.02 | Why? |
| Autopsy | 1 | 2021 | 3495 | 0.02 | Why? |
| Treatment Outcome | 3 | 2020 | 51732 | 0.02 | Why? |
| Macrophages | 1 | 2020 | 2784 | 0.02 | Why? |
| Data Collection | 1 | 2018 | 1769 | 0.02 | Why? |
| Inflammation | 2 | 2021 | 13255 | 0.02 | Why? |
| Cost-Benefit Analysis | 1 | 2018 | 2259 | 0.02 | Why? |
| Thrombophilia | 1 | 2020 | 1935 | 0.02 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2017 | 2309 | 0.02 | Why? |
| Body Mass Index | 1 | 2021 | 4306 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Transcriptome | 1 | 2021 | 3466 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Bacteremia | 1 | 2018 | 1372 | 0.02 | Why? |
| Infant, Newborn | 2 | 2017 | 23105 | 0.02 | Why? |
| Blood Coagulation | 1 | 2018 | 2768 | 0.02 | Why? |
| Signal Transduction | 1 | 2021 | 7207 | 0.02 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.02 | Why? |
| Research Design | 1 | 2018 | 5830 | 0.01 | Why? |
| Animals | 1 | 2010 | 78931 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.01 | Why? |
| Anticoagulants | 1 | 2020 | 9563 | 0.01 | Why? |
| Immunity, Innate | 1 | 2017 | 6570 | 0.01 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.01 | Why? |
| Quality of Life | 1 | 2018 | 9820 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Coinfection | 1 | 2017 | 6820 | 0.01 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
Vlaar's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(216)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(221)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_